- Home
- OPAD vs STRO Comparison
OPAD vs STRO Comparison
Compare OPAD & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAD
- STRO
- Stock Information
- Founded
- OPAD 2015
- STRO 2003
- Country
- OPAD United States
- STRO United States
- Employees
- OPAD N/A
- STRO N/A
- Industry
- OPAD Real Estate
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OPAD Finance
- STRO Health Care
- Exchange
- OPAD Nasdaq
- STRO Nasdaq
- Market Cap
- OPAD 89.3M
- STRO 96.6M
- IPO Year
- OPAD N/A
- STRO 2018
- Fundamental
- Price
- OPAD $2.70
- STRO $1.11
- Analyst Decision
- OPAD Hold
- STRO Hold
- Analyst Count
- OPAD 5
- STRO 7
- Target Price
- OPAD $2.41
- STRO $1.97
- AVG Volume (30 Days)
- OPAD 3.1M
- STRO 1.6M
- Earning Date
- OPAD 11-03-2025
- STRO 11-12-2025
- Dividend Yield
- OPAD N/A
- STRO N/A
- EPS Growth
- OPAD N/A
- STRO N/A
- EPS
- OPAD N/A
- STRO N/A
- Revenue
- OPAD $703,352,000.00
- STRO $104,473,000.00
- Revenue This Year
- OPAD N/A
- STRO $65.48
- Revenue Next Year
- OPAD $31.90
- STRO N/A
- P/E Ratio
- OPAD N/A
- STRO N/A
- Revenue Growth
- OPAD N/A
- STRO N/A
- 52 Week Low
- OPAD $0.91
- STRO $0.52
- 52 Week High
- OPAD $6.35
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- OPAD 39.65
- STRO 59.92
- Support Level
- OPAD $2.80
- STRO $1.02
- Resistance Level
- OPAD $2.98
- STRO $1.18
- Average True Range (ATR)
- OPAD 0.28
- STRO 0.12
- MACD
- OPAD -0.04
- STRO 0.02
- Stochastic Oscillator
- OPAD 24.05
- STRO 61.99
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.